The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has had a mixed day of trade on Thursday. In afternoon trade the index has given back its morning gains but is off its lows and flat at 5,779.4 points.
Four shares that are climbing more than most today are listed below. Here’s why they are storming higher today:
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is up 4% to $20.01 following the release of a positive announcement related to its SCENESSE product in the United States. According to the release, the US Food and Drug Administration has granted a Priority Review for SCENESSE on July 8, which could lead to the drug going on sale in the United States in the near future if it can satisfy requirements.
The Integrated Research Limited (ASX: IRI) share price has rocketed 32% higher to $2.20 after the global provider of proactive experience management solutions for critical IT infrastructure, payments and communications ecosystems released its guidance for the first half of FY 2019. Integrated Research has turned around its performance and expects to report a first half profit after tax in the range of $11.1 million to $11.7 million. This represents 19% to 26% growth on the prior corresponding period.
The Nearmap Ltd (ASX: NEA) share price is up 9% to $1.74 following the release of the geospatial map technology company’s preliminary half year results. Nearmap advised that at the end of December its annual contract value (ACV) stood at $78.3 million, up 42% on the prior corresponding period. This was driven by a 107% increase in U.S. ACV and a 23% lift in Australian ACV.
The Noni B Limited (ASX: NBL) share price has zoomed 13% higher to $2.83 after the fashion retailer provided a trading update. Noni B revealed that it had a strong Christmas trading period, recording positive like for like sales growth. This meant that for the six months ended December 31, total sales grew by a whopping 140% to approximately $457 million.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. The Motley Fool Australia has recommended Integrated Research Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.